Immunoglobulin G4 (IgG4)-releated disease is typically associated with interstitial nephritis, but rare cases of idiopathic membranous nephropathy as a renal manifestation have been described. Obinutuzumab was successfully used in refractory membranous nephropathy, but evidence for the treatment of IgG4-related disease with obinutuzumab is lacking. We report one patient's case with membranous nephropathy associated with IgG4-related disease who was treated with obinutuzumab following an anaphylactic reaction to rituximab. Obinutuzumab treatment resulted in a sustained complete remission of membranous nephropathy and a decrease of IgG4 to the normal range. This case demonstrates that membranous nephropathy associated with IgG4-related disease can be treated successfully with obinutuzumab.
CITATION STYLE
Ginthör, N. E., Artinger, K., Pollheimer, M. J., Stradner, M. H., & Eller, K. (2022). Membranous nephropathy associated with immunoglobulin G4-related disease successfully treated with obinutuzumab. Clinical Kidney Journal, 15(3), 564–566. https://doi.org/10.1093/ckj/sfab250
Mendeley helps you to discover research relevant for your work.